The global rapid microbiology testing market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4% during the forecast period. Growth in the rapid microbiology testing market is mainly driven by factors such as the increasing incidence of infectious disease and cancer, technological advancements in rapid microbiology testing, increased funding for R&D and increased focus on the early detection of infectious disease. However, the high capital investments and low cost-benefit ratio and unfavorable regulatory and reimbursement scenarios are the major factors hampering the growth of this market.
The major players in this market are Abbott Laboratories, Inc. (US), Becton, Dickinson and Company (US), bioMérieux SA (France), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), NEOGEN Corporation (US), Quidel Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Vivione Biosciences, LLC (US), Gradientech (Sweden), rqmicro AG (Switzerland), Bactest Ltd. (US), Colifast (Norway), Serosep Ltd. (Ireland), Biosensia (Ireland), Solus Scientific Solutions Ltd. (Scotland), LubioScience GmbH (Scotland), Euroclone SpA (Italy), CorDx (US), and R-Biopharm AG (Germany).
To know about the assumptions considered for the study download the pdf brochure
In 2020, Biomérieux SA held the leading position in the rapid microbiology testing market. It has a wide geographic presence that spans North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with a strong direct and indirect distribution network across the globe. To sustain its leading position in the market, the company pursues inorganic growth strategies. For instance, in July 2020, the company launched the BIOFIRE mycoplasma test for mycoplasma detection in biopharmaceutical products.
In 2020, Danaher Corporation accounted for the second-largest share of the rapid microbiology testing market. The company has maintained its leading position in the market through its strong distribution networks across North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The company adopts organic growth strategies to increase its dominance in this market. It also focuses on partnering with new businesses to complement its existing business segments. Such developments have enabled Danaher Corporation to add innovative technologies and products to its portfolio, which, in turn, has strengthened its presence in the rapid microbiology testing market.
Becton, Dickinson and Company leading position in this market can be attributed to its strong sales and distribution network across the globe, which enables it to effectively market its products in various countries. The company invests a significant amount of its revenue on R&D. This enables it to develop and launch new products in the market. In January 2020, the company released a new, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes. Such developments have strengthened the company’s position in the rapid microbiology testing market.
Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System, PCR, Mass Spectrometry), Method (Growth, Nucleic Acid, Viability), Applications (Clinical Diagnosis, Pharma, Environmental) - Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE